Page last updated: 2024-08-21

alpha-aminopyridine and Obstructive Lung Diseases

alpha-aminopyridine has been researched along with Obstructive Lung Diseases in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19902 (22.22)18.7374
1990's1 (11.11)18.2507
2000's4 (44.44)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chow, CW; Lau, CW; Sanderson, MP; Schnapp, A1
Diamant, Z; Spina, D1
Vij, N1
Christie, P1
Baur, X; Fruhmann, G; Hauser, F; Klepzig, M; Mernitz, G; Strauer, BE1
Barsig, J; Beume, R; Bundschuh, DS; Eltze, M; Hatzelmann, A; Wollin, L1
Magnussen, H; Scheidt-Mackes, M1
Chakraborty, TK; Filshie, RJ; Lee, MR1

Reviews

4 review(s) available for alpha-aminopyridine and Obstructive Lung Diseases

ArticleYear
Syk: a novel target for treatment of inflammation in lung disease.
    Inflammation & allergy drug targets, 2009, Volume: 8, Issue:2

    Topics: Aminopyridines; Animals; Anti-Inflammatory Agents; Clinical Trials as Topic; Humans; Intercellular Adhesion Molecule-1; Intracellular Signaling Peptides and Proteins; Leukocytes; Lung Diseases, Obstructive; Morpholines; Oxazines; Picornaviridae Infections; Pneumonia, Viral; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Respiratory Mucosa; Rhinovirus; Signal Transduction; Syk Kinase; Virulence; Virus Internalization

2009
PDE4-inhibitors: a novel, targeted therapy for obstructive airways disease.
    Pulmonary pharmacology & therapeutics, 2011, Volume: 24, Issue:4

    Topics: Aminopyridines; Benzamides; Clinical Trials, Phase III as Topic; Cyclic Nucleotide Phosphodiesterases, Type 7; Cyclohexanecarboxylic Acids; Cyclopropanes; Humans; Lung Diseases, Obstructive; Nitriles; Phosphodiesterase 4 Inhibitors

2011
Roflumilast: APTA 2217, B9302-107, BY 217, BYK 20869.
    Drugs in R&D, 2004, Volume: 5, Issue:3

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminopyridines; Benzamides; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Drugs, Investigational; Humans; Lung Diseases, Obstructive; Phosphodiesterase Inhibitors

2004
Roflumilast: a selective phosphodiesterase 4 inhibitor.
    Drugs of today (Barcelona, Spain : 1998), 2005, Volume: 41, Issue:10

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminopyridines; Animals; Anti-Inflammatory Agents; Benzamides; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Humans; Lung Diseases, Obstructive; Molecular Structure; Phosphodiesterase Inhibitors

2005

Trials

1 trial(s) available for alpha-aminopyridine and Obstructive Lung Diseases

ArticleYear
[The effect of flupirtine on respiratory drive in healthy probands and patients with various lung diseases].
    Pneumologie (Stuttgart, Germany), 1992, Volume: 46, Issue:11

    Topics: Airway Resistance; Aminopyridines; Analgesics; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Lung Diseases, Obstructive; Pulmonary Ventilation; Respiratory Center

1992

Other Studies

4 other study(ies) available for alpha-aminopyridine and Obstructive Lung Diseases

ArticleYear
Synthesis and evaluation of airway targeted PLGA nanoparticles for drug delivery in obstructive lung diseases.
    Methods in molecular biology (Clifton, N.J.), 2012, Volume: 906

    Topics: Aminopyridines; Benzodioxoles; Drug Delivery Systems; Epithelial Cells; Humans; Lactic Acid; Lung Diseases, Obstructive; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Transfection

2012
[Right ventricular hemodynamics and lung function following amrinone injection].
    Zeitschrift fur Kardiologie, 1984, Volume: 73, Issue:10

    Topics: Airway Resistance; Aminopyridines; Amrinone; Cardiotonic Agents; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Lung Diseases, Obstructive; Lung Volume Measurements; Myocardial Contraction

1984
In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 297, Issue:1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Oral; Aminopyridines; Animals; Anti-Asthmatic Agents; Benzamides; Bronchoconstriction; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Dose-Response Relationship, Drug; Guinea Pigs; Lipopolysaccharides; Lung Diseases, Obstructive; Male; Ovalbumin; Phosphodiesterase Inhibitors; Rats; Rats, Inbred BN; Rats, Sprague-Dawley; Trachea; Tumor Necrosis Factor-alpha

2001
Methaemoglobinaemia produced by phenazopyridine (Pyridium) in a man with chronic obstructive airways disease.
    Scottish medical journal, 1987, Volume: 32, Issue:6

    Topics: Aged; Aminopyridines; Carcinoma in Situ; Humans; Lung Diseases, Obstructive; Male; Methemoglobinemia; Phenazopyridine; Urinary Bladder Neoplasms

1987